Monkeypox is not an international health emergency yet – WHO

World Health Organization (WHO / OMS) Headquarters - Geneva, Switzerland

diegograndi/iStock Editorial via Getty Images

Following a meeting of its Emergency Committee, the World Health Organization (WHO) has decided that the current outbreak of monkeypox does not amount to a Public Health Emergency of International Concern (PHEIC), the global body said on Saturday.

PHEIC designation is WHO's highest level of warning, previously issued for the COVID-19 pandemic and Ebola.

During the Thursday's meeting, the WHO shared data on the current epidemiological situation of the rare viral disease, highlighting that since the start of May, more than 47 countries reported 3,040 monkeypox cases.

Despite a few dissenting views, “the committee resolved by consensus to advise the WHO Director-General that at this stage the outbreak should be determined to not constitute a PHEIC,” the WHO said regarding the outcome of the meeting.

However, the panel noted that the outbreak requires close monitoring and review to determine if there are significant changes that will warrant reconsideration of their advice.

Vaccine developers for monkeypox: Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), Chimerix (CMRX).

Developers of therapeutics for monkeypox: GeoVax Labs (GOVX), SIGA Technologies (NASDAQ:SIGA) and Tonix Pharmaceuticals (TNXP).

Monkeypox test makers: Co-Diagnostics (CODX), Roche (OTCQX:RHHBY) (OTCQX:RHHBF), Abbott Laboratories (ABT)

Read: Companies with solutions for monkeypox surged in May after the WHO convened an emergency meeting of experts to discuss the outbreak.

Recommended For You

Comments (43)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.